Prediction of warfarin dose: why, when and how?

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.4, 2012-03, pp. : 429-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gamma-Secretase as a Pharmacological Target in Alzheimer Disease Research: When, Why and How?

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4313-4335

Bentham Science Publishers

Access to resources Recommend Favorite

Unique/Major Human Metabolites: Why, How, and When to Test for Safety in Animals

By Luffer-Atlas Debra

Drug Metabolism Reviews, Vol. 40, Iss. 3, 2008-07 ,pp. : 447-463

Informa Healthcare

Access to resources Recommend Favorite

NO to Breast: When, Why and Why Not?

Current Pharmaceutical Design, Vol. 16, Iss. 4, 2010-02 ,pp. : 451-462

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction score for major haemorrhage with warfarin

Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Factors influencing warfarin dose requirements in African––Americans

By Momary Kathryn M Shapiro Nancy L Viana Marlos AG Nutescu Edith A Helgason Cathy M Cavallari Larisa H

Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. : 1535-1544

Future Medicine

Access to resources Recommend Favorite